Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome

businesswire

Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome – NEWSnet – News… as it used to be

More Press Releases

June 16, 2026

Daymond John and the RedPocket Mobiles Drop “Color Rush” Jersey — and Two Fans Get to Pitch the People’s Shark

June 16, 2026

SAIL Investors Have Opportunity to Join SailPoint, Inc. Fraud Investigation with the Schall Law Firm

June 16, 2026

Teledyne FLIR Defense Unveils Three Vehicle Vision Systems for Enhanced Battlefield Awareness

June 16, 2026

Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome

Daymond John and the RedPocket Mobiles Drop “Color Rush” Jersey — and Two Fans Get to Pitch the People’s Shark

SAIL Investors Have Opportunity to Join SailPoint, Inc. Fraud Investigation with the Schall Law Firm

Teledyne FLIR Defense Unveils Three Vehicle Vision Systems for Enhanced Battlefield Awareness

ABB Robotics and PSYONIC Use Human-Generated Data to Advance Robotic Dexterity